![Narinder Singh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Narinder Singh
Keine laufenden Positionen mehr
Profil
Narinder Singh worked at Momenta Pharmaceuticals, Inc. as VP-Drug Product Development & Manufacturing from 2015 to 2018.
Then worked at Genocea Biosciences, Inc. as Senior VP-Pharmaceutical Sciences & Manufacturing from 2018 to 2020.
Served at Aimmune Therapeutics, Inc. as Executive Vice President-Technical Operations from 2020 to 2021.
Held the position of Chief Technology Officer at Forte Biosciences, Inc. in 2021.
Held the position of Chief Technology Officer at Arcellx, Inc. from 2021 to 2026.
Education includes undergraduate and graduate degrees from Indian Institute of Technology New Delhi in 1994 and 1995, respectively, a graduate degree from the University of Houston in 1997, and an MBA from UCLA Anderson School of Management in 2004.
Ehemalige bekannte Positionen von Narinder Singh
| Unternehmen | Position | Ende |
|---|---|---|
| ARCELLX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.04.2026 |
| FORTE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
| AIMMUNE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2021 |
| GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 01.07.2020 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2018 |
Ausbildung von Narinder Singh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
University of Houston
 University of Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indian Institute of Technology New Delhi
 Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Forte Biosciences, Inc.
 Forte Biosciences, Inc. BiotechnologyHealth Technology Provides dermatological therapies and related services | Health Technology |
